The life science group Sartorius refinanced its syndicated loan, increasing it to 600 million euros. The company signed a loan agreement with an international bank syndicate led by BNP Paribas, Commerzbank, and UniCredit. Sartorius has now adjusted its credit facility in place so far to accommodate its strong growth. As a result, the company has raised its credit line that will run until the end of 2021 by 200 million euros and extended the members of the bank syndicate by J.P. Morgan and UniCredit.
“The new loan agreement ensures our financing flexibility following the company’s three acquisitions in 2020, providing leeway for further strategic measures. We took out this loan under highly attractive terms in a market environment of tightening financial conditions. This reflects the confidence of banks in the financial strength and positive prospects of Sartorius,” said Rainer Lehmann, member of the Executive Board and Chief Financial Officer of Sartorius. The credit line is for a term of three years and can be extended twice for one year at a time.
Un estudio con datos de los últimos 35 años, ind...
Un equipo de investigadores de la Universidad Juli...
A new technique allows the design of solid materia...
En nuestro post hablamos sobre este interesante tipo de célula del si...
Han desarrollado un estudio para evaluar la correlación entre el teji...
Portal de biotecnología en España
¡Suscríbase a nuestro newsletter para estar al día con las últimas noticias y ofertas!
2013 © Biotech-Spain.com - Site Developments SL. Todos los derechos reservados. Terminos y Condiciones | Política de Privacidad
Articles
Directory